CRMD Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CRMD's estimated annual revenue is currently $2.3M per year.(i)
  • CRMD's estimated revenue per employee is $101,500

Employee Data

  • CRMD has 23 Employees.(i)
  • CRMD grew their employee count by 35% last year.

CRMD's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Senior Salesforce Project ManagerReveal Email/Phone
3
Sr Salesforce ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$76.3M4211%N/AN/A
#2
$1715.6M39403%$23.4MN/A
#3
$40.2M25226%N/AN/A
#4
$265.8M1282-4%$38MN/A
#5
$24.2M155-17%$78.9MN/A
#6
$763.6M13034%$1.8MN/A
#7
$12.5M86-44%$19.5MN/A
#8
$67.4M372-9%N/AN/A
#9
$67.8M368-46%$130MN/A
#10
$27.1M17036%N/AN/A
Add Company

What Is CRMD?

CRMD is an ultramodern consulting firm focused on strategy, technology, and business transformation. Serving the globe, CRMD was founded in — and remains headquartered in — the home of the Red Sox, Boston. Our cumulative expert-experience surpasses 2,000 agile Salesforce projects, but our real value is in our no-BS model, which resonates with local and friendly teammates who will feel like extensions of your own team. Twitter: @CRMDsolutions Instagram: CRMDsolutions Facebook: https://www.facebook.com/CRMDsolutions/

keywords:N/A

N/A

Total Funding

23

Number of Employees

$2.3M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CRMD News

2022-04-17 - CorMedix (NYSEAMERICAN:CRMD) Lowered to “Sell” at ...

CorMedix (NYSEAMERICAN:CRMD) Lowered to “Sell” at Zacks Investment Research. Posted by admin on Apr 20th, 2022. Share on Twitter Share on Facebook Share on...

2022-03-30 - CorMedix Inc Common Stock (CRMD) Q4 2021 Earnings Call ...

CRMD earnings call for the period ending December 31, 2021. Logo of jester cap with thought bubble. Image source: The Motley Fool. CorMedix Inc...

2022-03-22 - CRMD stock rises on FDA acceptance of marketing ...

CorMedix (CRMD) has developed its lead asset DefenCath as a catheter lock solution for initial use in the reduction of catheter-related...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M23-18%N/A
#2
$2.1M23-15%N/A
#3
$4M23N/AN/A
#4
$2.3M23N/AN/A
#5
$2.3M23N/AN/A